GALNT12 Knockout cell line (TPC-1)
Catalog Number: KOA53513
Price: Online Inquiry
Catalog Number: KOA53513
Price: Online Inquiry
| Product Information | |
|---|---|
| Product Name | GALNT12 Knockout cell line (TPC-1) |
| specification | 1*10^6 |
| Storage and transportation | Shipped on dry ice; Store in liquid nitrogen |
| Cell morphology | Epithelial-like, adherent |
| Passage ratio | 1:5-1:8 |
| species | Human |
| Gene | GALNT12 |
| Gene ID | 79695 |
| Build method | Electroporation/Lentivirus |
| Mycoplasma testing | negative |
| Cultivation system | 90%DMEM+10%FBS |
| Parental Cell Line | TPC-1 |
| Quality Control | Genotype: GALNT12 Knockout cell line (TPC-1)>95% viability before freezing. All cells were tested and found to be free of bacterial, viruses,mycoplasma and other toxins. |
| Gene Information | |
|---|---|
| Gene Official Full Name | polypeptide N-acetylgalactosaminyltransferase 12provided by HGNC |
| Also known as | CRCS1; GalNAc-T12 |
| Gene Description | This gene encodes a member of a family of UDP-GalNAc:polypeptide N-acetylgalactosaminyltransferases, which catalyze the transfer of N-acetylgalactosamine (GalNAc) from UDP-GalNAc to a serine or threonine residue on a polypeptide acceptor in the initial step of O-linked protein glycosylation. Mutations in this gene are associated with an increased susceptibility to colorectal cancer.[provided by RefSeq, Mar 2011] |
| Expression | Biased expression in colon (RPKM 24.5), stomach (RPKM 17.8) and 12 other tissues See more |
Please note that all services are for research use only. Not intended for any clinical use.
If your question is not addressed through these resources, you can fill out the online form below and we will answer your question as soon as possible.
|
There is no product in your cart. |
CD Biosynsis is a leading customer-focused biotechnology company dedicated to providing high-quality products, comprehensive service packages, and tailored solutions to support and facilitate the applications of synthetic biology in a wide range of areas.